"You decide and we provide."
Cart 0

Loxo's targeted drug helps variety of advanced cancers in small study




reutersCOMPANYNEWS companyNews

June 3 (Reuters) - Three quarters of patients with a wide variety of advanced cancers responded to a Loxo Oncology Inc therapy that targets a specific genetic defect, according to data from a small study presented on Saturday at the year's most important oncology meeting.




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published